Acceliant Transforms one of the largest eClinical Studies

Objective

A leading Fortune 500 pharma multinational in US was looking for an EDC solution for their late phase Immunology and infectious disease TA. Since the quantum of trial Parameter was enormous, the client wanted to have a platform which can be scalable quickly as the trial progresses.

Benefits

Acceliant helped by:-

  1. Creating multiple version of CRF.
  2. System Performance – 250 real time concurrent user access the system without any lag.
  3. Easy and configurable query work flow – As the trial as huge Adverse events.

 

case 1.png

CONTACT US TODAY

By submitting your information, you agree to our revised Privacy Policy.

Share this post

You might also like...

Lupin Implements Acceliant Platform for BA/BE studies

Objective- Lupin was looking for a robust platform for their clinical studies which has a best in breed user interface and is also cost effective....

Continue Reading >

Watch: How we add value

Want to know more? Talk to us.

Contact us+1-408-387-5800